阅读说明：本技术 用于早期肺癌预后的基于血浆的蛋白质概况分析 (Plasma-based protein profiling for early lung cancer prognosis ) 是由 C·戈贝尔 C·劳登 T·C·龙 于 2018-04-04 设计创作，主要内容包括：本发明提供了能够用于非小细胞肺癌诊断的生物标志物和生物标志物的组合。将这些生物标志物的测量值输入分类系统,诸如随机森林,以协助确定个体具有非小细胞肺癌的可能性。还提供了包含用于检测生物标志物和生物标志物组合的试剂盒以及协助诊断非小细胞肺癌的系统。(The present invention provides biomarkers and combinations of biomarkers that can be used for the diagnosis of non-small cell lung cancer. Measurements of these biomarkers are input into a classification system, such as a random forest, to assist in determining the likelihood that an individual has non-small cell lung cancer. Also provided are kits comprising the use for detecting biomarkers and biomarker combinations and systems that assist in the diagnosis of non-small cell lung cancer.)